|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.
The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Canaccord Genuity on July 23, 2021. The analyst firm set a price target for 29.00 expecting MCRB to rise to within 12 months (a possible 317.87% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $6.94 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Seres Therapeutics.
There is no upcoming split for Seres Therapeutics.
Seres Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.